Autophagy is the process by which cells digest and renew their internal structures, recycling damaged or malfunctioning proteins and organelles. By reusing these basic molecules, the cell gains the ...
The percentage of U.S. adults with obesity did not significantly rise from 2013 to 2023, though a small uptick in the rate of obesity was seen for children and adolescents, according to data published ...
Novo Nordisk ( NVO -2.98%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...
The vote puts a longtime critic of vaccines and the medical establishment in charge of the nation’s vast and powerful health ...
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just<a class="excerpt-read-more" href=" More ...
Ultra-processed foods (UPFs) have become the latest villain in our never-ending search for an easy scapegoat. But before we ...
ATLANTA — The fourth annual Healthy Georgia report from the Augusta University School of Public Health came out and shows how ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A new study breaks down several cases of Ozempic blindness, linked to semaglutide and tirzepatide. Here's what could be behind this.
Knownwell, which so far only has one clinic in Boston and another in Dallas, sees a chance to pounce on an unaddressed need ...
Novo Nordisk shares dropped due to CagriSema trial results but have long-term upside. Learn why NVO stock is a Strong Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results